GlaxoSmithKline PLC Director/PDMR Shareholding- Amendment (3136C)
16 January 2015 - 2:50AM
UK Regulatory
TIDMGSK
RNS Number : 3136C
GlaxoSmithKline PLC
15 January 2015
This announcement replaces the original announcement released on
5 January 2015 at 14.30pm (RNS No: 3069B).
Notification of Transactions of Directors, Persons Discharging
Managerial Responsibility or Connected Persons
I give below details of changes in the Directors' interests in
the Ordinary Shares and American Depositary Shares (ADSs) of
GlaxoSmithKline plc (the 'Company').
On 31 December 2014, the Company's Non-Executive Directors were
provisionally allocated the following awards over Ordinary Shares
and ADSs in the Company through the annual reinvestment of
dividends paid throughout 2014; calculated using an average price
of GBP13.84 per Ordinary Share and $42.91 per ADS:
Non-Executive Ordinary Shares No. of ADSs
Director
Sir Christopher
Gent 6,385.452
Prof Sir Roy
Anderson 1,003.260
Dr Stephanie
Burns 886.521
Stacey Cartwright 256.043
Lynn Elsenhans 308.422
Judy Lewent 208.857
Sir Deryck Maughan 2,255.597
Dr Daniel Podolsky 1,613.970
Tom de Swaan 1,389.497
Jing Ulrich 98.139
Hans Wijers 76.661
The Company and the Non-Executive Directors were informed of
these allocations on 5 January 2015.
This notification relates to transactions notified in accordance
with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
15 January 2015
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSBUGDBUSBBGUU
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2024 to May 2024
Gsk (LSE:GSK)
Historical Stock Chart
From May 2023 to May 2024